Antibody therapies can remove amyloid plaques from the brain and slow cognitive decline in people with Alzheimer's disease ...

An update from Prophase Labs ( (PRPH) ) is now available.

ProPhase Labs is embarking on a significant financial restructuring, pivoting its strategy to bolster its balance sheet. The company has formally initiated the sale process for its esophageal cancer ...

An update from Prophase Labs ( (PRPH)) is now available. On December 29, 2025, ProPhase Labs, Inc. disclosed that it had failed to regain compliance with Nasdaq’s $1.00 minimum bid price requirement ...

(MENAFN- GlobeNewsWire - Nasdaq) UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET.

UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. A live question and answer session ...

UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. ProPhase Labs Inc. (Nasdaq: PRPH) ...

UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH) announced Wednesday it is engaged in merger and acquisition discussions that could potentially recognize the company’s value "at multiples of its ...

ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important. Next-Phase Commercialization of BE-Smart™ ...

ProPhase Labs (PRPH) reminds shareholders of record as of October 20, 2025, of the Company’s upcoming Special Meeting of Stockholders, which will be held on November 24, 2025. The company said, “By ...